162 related articles for article (PubMed ID: 38783953)
1. Improving prediction of tacrolimus concentration using a combination of population pharmacokinetic modeling and machine learning in chinese renal transplant recipients.
Wang YP; Lu XL; Shao K; Shi HQ; Zhou PJ; Chen B
Front Pharmacol; 2024; 15():1389271. PubMed ID: 38783953
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.
Li ZR; Li RD; Niu WJ; Zheng XY; Wang ZX; Zhong MK; Qiu XY
J Clin Pharmacol; 2023 Mar; 63(3):314-325. PubMed ID: 36097320
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
[TBL] [Abstract][Full Text] [Related]
4. Impact of Donor and Recipient
Shao J; Wang C; Fu P; Chen F; Zhang Y; Wei J
Ann Pharmacother; 2020 Jul; 54(7):652-661. PubMed ID: 31888346
[No Abstract] [Full Text] [Related]
5. A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Lloberas N; Grinyó JM; Colom H; Vidal-Alabró A; Fontova P; Rigo-Bonnin R; Padró A; Bestard O; Melilli E; Montero N; Coloma A; Manonelles A; Meneghini M; Favà A; Torras J; Cruzado JM
Kidney Int; 2023 Oct; 104(4):840-850. PubMed ID: 37391040
[TBL] [Abstract][Full Text] [Related]
6. Machine learning-based method for tacrolimus dose predictions in Chinese kidney transplant perioperative patients.
Fu Q; Jing Y; Liu Mr G; Jiang Mr X; Liu H; Kong Y; Hou X; Cao L; Deng P; Xiao P; Xiao J; Peng H; Wei X
J Clin Pharm Ther; 2022 May; 47(5):600-608. PubMed ID: 34802160
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction.
Huang Q; Lin X; Wang Y; Chen X; Zheng W; Zhong X; Shang D; Huang M; Gao X; Deng H; Li J; Zeng F; Mo X
Front Pharmacol; 2022; 13():942129. PubMed ID: 36457704
[No Abstract] [Full Text] [Related]
8. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.
Chen B; Shi HQ; Liu XX; Zhang WX; Lu JQ; Xu BM; Chen H
J Clin Pharm Ther; 2017 Dec; 42(6):679-688. PubMed ID: 28833329
[TBL] [Abstract][Full Text] [Related]
9. Dosage optimization of tacrolimus based on the glucocorticoid dose and pharmacogenetics in adult patients with systemic lupus erythematosus.
Wang CB; Zhang YJ; Zhao MM; Zhao L
Int Immunopharmacol; 2023 Nov; 124(Pt A):110866. PubMed ID: 37678026
[TBL] [Abstract][Full Text] [Related]
10. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients.
Wang XH; Shao K; An HM; Zhai XH; Zhou PJ; Chen B
Eur J Clin Pharmacol; 2022 Aug; 78(8):1261-1272. PubMed ID: 35536394
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus population pharmacokinetic models according to CYP3A5/CYP3A4/POR genotypes in Chinese Han renal transplant patients.
Zhu W; Xue L; Peng H; Duan Z; Zheng X; Cao D; Wen J; Wei X
Pharmacogenomics; 2018 Aug; 19(13):1013-1025. PubMed ID: 30040022
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
[TBL] [Abstract][Full Text] [Related]
14. Application of machine learning combined with population pharmacokinetics to improve individual prediction of vancomycin clearance in simulated adult patients.
Li G; Sun Y; Zhu L
Front Pharmacol; 2024; 15():1352113. PubMed ID: 38562463
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models.
Wang D; Lu J; Li Q; Li Z
Exp Ther Med; 2019 May; 17(5):4023-4031. PubMed ID: 31007740
[TBL] [Abstract][Full Text] [Related]
16. Prediction of tacrolimus and Wuzhi tablet pharmacokinetic interaction magnitude in renal transplant recipients.
Chen P; Dai R; She Y; Fu Q; Huang M; Chen X; Wang C
Clin Transplant; 2022 Dec; 36(12):e14807. PubMed ID: 36057787
[TBL] [Abstract][Full Text] [Related]
17. Effect of drug combination on tacrolimus target dose in renal transplant patients with different
Zhang SF; Tang BH; Wei AH; Du Y; Guan ZW; Li Y
Xenobiotica; 2022 Mar; 52(3):312-321. PubMed ID: 35395919
[TBL] [Abstract][Full Text] [Related]
18. The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients.
Chen Z; Cheng X; Zhang L; Tang L; Fang Y; Chen H; Zhang L; Shen A
Pharmacol Rep; 2021 Oct; 73(5):1418-1426. PubMed ID: 34089513
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review.
Wang CB; Zhang YJ; Zhao MM; Zhao LM
Eur J Clin Pharmacol; 2023 Jul; 79(7):897-913. PubMed ID: 37261481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
